MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

MDT

96.67

+0.59%↑

A

137.56

-0.2%↓

VEEV

224.65

-0.07%↓

HQY

91.97

-0.76%↓

PHR.US

17

+0.18%↑

Search

Inspire Medical Systems Inc

Cerrado

SectorSanidad

92.62 -1.23

Resumen

Variación precio

24h

Actual

Mínimo

90.49

Máximo

93.86

Métricas clave

By Trading Economics

Ingresos

14M

9.9M

Ventas

7.4M

225M

P/B

Media del Sector

66.169

78.892

BPA

0.38

Margen de beneficios

4.424

Empleados

1,246

EBITDA

16M

17M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+51.36% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

716M

2.9B

Apertura anterior

93.85

Cierre anterior

92.62

Noticias sobre sentimiento de mercado

By Acuity

81%

19%

355 / 374 Clasificación en Healthcare

Inspire Medical Systems Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 dic 2025, 22:03 UTC

Principales Movimientos del Mercado

Mining Stocks Slip Near the End of Stellar Year

29 dic 2025, 15:57 UTC

Principales Movimientos del Mercado

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29 dic 2025, 23:43 UTC

Charlas de Mercado

Nikkei May Decline; Yen in Focus -- Market Talk

29 dic 2025, 23:38 UTC

Adquisiciones, fusiones, absorciones

Manus: Will Continue to Operate From Singapore

29 dic 2025, 23:38 UTC

Adquisiciones, fusiones, absorciones

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29 dic 2025, 23:37 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms: Will Integrate Manus Service Into Products

29 dic 2025, 23:36 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms: Will Continue to Operate, Sell Manus Service

29 dic 2025, 23:36 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29 dic 2025, 23:35 UTC

Adquisiciones, fusiones, absorciones

Manus to Join Meta Platforms

29 dic 2025, 21:33 UTC

Adquisiciones, fusiones, absorciones

Origin: Raise Values Kraken at US$8.65 Billion

29 dic 2025, 21:33 UTC

Adquisiciones, fusiones, absorciones

Origin: Octopus Targeting Kraken Separation by Mid 2026

29 dic 2025, 21:31 UTC

Adquisiciones, fusiones, absorciones

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29 dic 2025, 21:31 UTC

Adquisiciones, fusiones, absorciones

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Origin's Kraken Stake to Remain at 22.7%

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Origin: Additional Interest Offsets Dilution From Raise

29 dic 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29 dic 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29 dic 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29 dic 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29 dic 2025, 21:27 UTC

Adquisiciones, fusiones, absorciones

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29 dic 2025, 20:22 UTC

Charlas de Mercado

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29 dic 2025, 20:14 UTC

Charlas de Mercado

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29 dic 2025, 20:02 UTC

Adquisiciones, fusiones, absorciones

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29 dic 2025, 17:36 UTC

Charlas de Mercado

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Comparación entre iguales

Cambio de precio

Inspire Medical Systems Inc previsión

Precio Objetivo

By TipRanks

51.36% repunte

Estimación a 12 Meses

Media 144.5 USD  51.36%

Máximo 180 USD

Mínimo 91 USD

De acuerdo con 19 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Inspire Medical Systems Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

19 ratings

13

Comprar

6

Mantener

0

Vender

Sentimiento

By Acuity

355 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
help-icon Live chat